Literature DB >> 21370939

Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.

Richard Dwyer1, Jonas Hedlund, Jessica Darenberg, Birgitta Henriques-Normark, Pontus Naucler, Sara Runesdotter, Mats Kalin.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) is the leading cause of hospitalization among infectious diseases, and is mainly caused by Streptococcus pneumoniae. Modifications were tested to improve the accuracy of CRB-65 as a simple but useful bedside scoring system, and to compare it with 3 established severity scoring systems (PSI, CURB-65 and CRB-65) to predict 30-day mortality in bacteraemic pneumococcal CAP.
METHODS: A retrospective analysis was performed on data from 375 adult patients with bacteraemic pneumococcal pneumonia. Mortality, sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic (ROC) curve were calculated for stratifications of the PSI, CURB-65 and CRB-65. The prognostic accuracy after addition of underlying disease and/or a peripheral oxygen saturation (SaO₂) < 90% was evaluated (DS CRB-65).
RESULTS: The mean age of the patients was 61.5 y, and the 30-day mortality was 9%. Coexisting conditions defined according to the pneumonia severity index (PSI) rule (malignancy, liver, cerebrovascular, and renal disease and congestive heart failure, p = 0.006) and SaO₂ < 90% (p < 0.0001) were independently associated with mortality. By adding these variables, the area under the ROC curve of CRB-65 increased from 0.77 (95% confidence interval (CI) 0.66-0.84) to 0.83 (95% CI 0.73-0.89) (p = 0.01), similar to that of PSI (0.84) and CURB-65 (0.81).
CONCLUSIONS: Modification of CRB-65 with the addition of 1 point for the presence of any underlying disease according to the PSI rule, and with 1 point if SaO₂ was < 90%, increased its prognostic accuracy in bacteraemic pneumococcal pneumonia with retained independence of laboratory data. The modified CRB-65 may have potential use in the assessment of prognosis in patients with CAP.

Entities:  

Mesh:

Year:  2011        PMID: 21370939     DOI: 10.3109/00365548.2011.562529

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Validation of the CORB75 (confusion, oxygen saturation, respiratory rate, blood pressure, and age ≥ 75 years) as a simpler pneumonia severity rule.

Authors:  O Ochoa-Gondar; A Vila-Corcoles; T Rodriguez-Blanco; I Hospital; E Salsench; X Ansa; N Saun
Journal:  Infection       Date:  2013-11-29       Impact factor: 3.553

2.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

3.  The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients.

Authors:  Phyo Kyaw Myint; Chun Shing Kwok; Sumit R Majumdar; Dean T Eurich; Allan B Clark; Pedro P España; Shin Yan Man; David T Huang; Donald M Yealy; Derek C Angus; Alberto Capelastegui; Timothy H Rainer; Thomas J Marrie; Michael J Fine; Yoon K Loke
Journal:  BMJ Open       Date:  2012-05-21       Impact factor: 2.692

4.  Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia.

Authors:  Richard Dwyer; Jonas Hedlund; Birgitta Henriques-Normark; Mats Kalin
Journal:  BMJ Open Respir Res       Date:  2014-07-08

5.  Implementation of Drive-Through Testing for COVID-19 With Community Paramedics.

Authors:  S Tyler Constantine; David Callaway; Jeremy N Driscoll; Stephanie Murphy
Journal:  Disaster Med Public Health Prep       Date:  2021-02-16       Impact factor: 1.385

6.  Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).

Authors:  Ilija Kuzman; Alexandr Bezlepko; Irena Kondova Topuzovska; László Rókusz; Liudmyla Iudina; Hans-Peter Marschall; Thomas Petri
Journal:  BMC Pulm Med       Date:  2014-06-30       Impact factor: 3.317

Review 7.  Advances in the prevention, management, and treatment of community-acquired pneumonia.

Authors:  Mathias W Pletz; Gernot G Rohde; Tobias Welte; Martin Kolditz; Sebastian Ott
Journal:  F1000Res       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.